IL6 and non-small cell lung carcinoma: Here, using the clinical microarray database of NSCLC [39], we disclosed that NSCLC patients with low level of HIC1 and high IL-6 expression had greatly poorer OS and MFS than the patients with high level of HIC1 and low IL-6 expression.